Why Need to Watch: Alexion Pharmaceuticals (NASDAQ:ALXN), Solar3D (NASDAQ:SLTD), Boston Scientific Corporation (NYSE:BSX), Financial Institutions Inc. (NASDAQ:FISI), OvaScience (NASDAQ:OVAS)


On Friday shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) closed at $180.59. Company’s sales growth for last 5 years was 42.00% and EPS growth for next 5 years is recorded as 24.73%. Cheshire’s Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) said William Keller has decided to retire from its board of directors after its May annual meeting.

Solar3D, Inc. (NASDAQ:SLTD) in last trading activity increased 7.26% to close at $4.58. Company weekly performance is 45.40% while its quarterly performance stands at -0.43%. Solar3D, Inc. (NASDAQ:SLTD) is -48.42% away from its 52 week high. On 19 March, Solar3D, Inc. (NASDAQ: SLTD), announced that its MD Energy subsidiary has secured a $2.4 million contract from the Rancho Mirage Public Library to install a complex solar system designed to protect against rising electric utility costs.

Boston Scientific Corporation (NYSE:BSX) in last trading activity advanced 2.24% to close at $17.83. Company weekly performance is -0.06% while its quarterly performance stands at 35.80%. Boston Scientific Corporation (NYSE:BSX) is -1.87% away from its 52 week high. This week, three patients in the US received the first implants of the Boston Scientific Corporation (NYSE:BSX) Watchman Left Atrial Appendage Closure (LAAC) device. The Watchman device offers a novel stroke risk reduction option for high-risk patients with non-valvular atrial fibrillation (AF) who are seeking an alternative to long-term warfarin therapy. The Watchman device received US Food and Drug Administration (FDA) approval on Friday, March 13, 2015.

Financial Institutions Inc. (NASDAQ:FISI) has 1.70% insider ownership while its institutional ownership stands at 59.30%. In last trading activity company’s stock closed at $22.83. On 18 March 2015, Financial Institutions Inc. (NASDAQ: FISI) has filed a document with the U.S. Securities and Exchange Commission to sell as much as $100 million of stock and debt in one or more offerings. There are no plans to conduct a sale right now, but the option is there if the need arises.

On last trading day OvaScience, Inc. (NASDAQ:OVAS) fell -9.98% to close at $43.47. Its volatility for the week is 12.82% while volatility for the month is 8.19%. OvaScience, Inc. (NASDAQ:OVAS) monthly performance is -7.61%. OvaScience Inc shares were off nearly 6 percent Friday following a company conference call with analysts concerning its fertility treatment.


Leave a Reply

Your email address will not be published. Required fields are marked *